Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery

The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial

(2014) N. E. Drury et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake

(2013) Nigel E. Drury et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome

(2012) Xiaoke Yin et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy

(2011) Neil J. Howell et al.   CIRCULATION

Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy

(2010) Khalid Abozguia et al.   CIRCULATION

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

(2008) et al.   CIRCULATION